Challenges in Nanogrinding of Active Pharmaceutical Ingredients

The production of nanosuspensions via stirred-media milling has proved to be an effective method to overcome bioavailability challenges of poorly water-soluble active pharmaceutical ingredients (APIs). The fine-grinding of the APIs cinnarizine and fenofibrate was investigated. Important process parameters were varied and the influence on product quality was studied. Different challenges were identified prior to and during milling: Foaming inside the milling equipment and agglomeration of fenofibrate occurred, and a long-term grinding experiment for cinnarizine revealed an increase in particle size, caused by ripening of the drug crystals during milling. Thus, the stability against ripening during the process is a newly identified challenge for the fine-grinding of APIs.

[1]  Michael Juhnke,et al.  Accelerated Formulation Development for Nanomilled Active Pharmaceutical Ingredients Using a Screening Approach , 2010 .

[2]  R. Davé,et al.  A study of the physical stability of wet media-milled fenofibrate suspensions using dynamic equilibrium curves , 2013 .

[3]  S. Shimabayashi,et al.  Interaction between hydroxypropylcellulose and surfactant and its effect on dispersion stability of kaolinite suspension in an aqueous phase , 1997 .

[4]  T. Liu,et al.  Dynamic Light Scattering of Rigid Rods – A Universal Relationship on the Apparent Diffusion Coefficient as Revealed by Numerical Studies and Its Use for Rod Length Determination , 2012 .

[5]  André R Studart,et al.  Ultrastable particle-stabilized foams. , 2006, Angewandte Chemie.

[6]  Arno Kwade,et al.  A Stressing Model for the Description and Optimization of Grinding Processes , 2003 .

[7]  E. Bilgili,et al.  A combined microhydrodynamics-polymer adsorption analysis for elucidation of the roles of stabilizers in wet stirred media milling. , 2012, International journal of pharmaceutics.

[8]  Barrett E. Rabinow,et al.  Nanosuspensions in drug delivery , 2004, Nature Reviews Drug Discovery.

[9]  Bernard P. Binks,et al.  Outstanding Stability of Particle-Stabilized Bubbles , 2003 .

[10]  G. Van den Mooter,et al.  Review: physical chemistry of solid dispersions , 2009 .

[11]  Michael Juhnke,et al.  Generation of wear during the production of drug nanosuspensions by wet media milling. , 2012, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[12]  Arno Kwade,et al.  Breaking characteristics of different materials and their effect on stress intensity and stress number in stirred media mills , 2002 .

[13]  Marco Mazzotti,et al.  Role of Milling Parameters and Particle Stabilization on Nanogrinding of Drug Substances of Similar Mechanical Properties , 2011 .

[14]  W. Peukert,et al.  Nanoparticle Production with Stirred-Media Mills: Opportunities and Limits , 2010 .

[15]  Jörg Schwedes,et al.  Motion and stress intensity of grinding beads in a stirred media mill. Part 2: Stress intensity and its effect on comminution , 1996 .

[16]  I. Colombo,et al.  Drug mechanochemical activation. , 2009, Journal of pharmaceutical sciences.

[17]  I. Ghosh,et al.  Optimization of formulation and process parameters for the production of nanosuspension by wet media milling technique: effect of Vitamin E TPGS and nanocrystal particle size on oral absorption. , 2012, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[18]  D. Hauss.  Oral lipid-based formulations. , 2007, Advanced drug delivery reviews.

[19]  Elaine Merisko-Liversidge,et al.  Nanosizing for oral and parenteral drug delivery: a perspective on formulating poorly-water soluble compounds using wet media milling technology. , 2011, Advanced drug delivery reviews.

[20]  A. Kwade,et al.  Produktgestaltung bei der Nanozerkleinerung durch Einsatz kleinster Mahlkörper , 2009 .

[21]  M. Mazzotti,et al.  Miconazole nanosuspensions: Influence of formulation variables on particle size reduction and physical stability. , 2010, International journal of pharmaceutics.

[22]  Patrick Augustijns,et al.  Top-down production of drug nanocrystals: nanosuspension stabilization, miniaturization and transformation into solid products. , 2008, International journal of pharmaceutics.